We are live on ! Find out more
CIC

Carnegie Investment Counsel Portfolio holdings

AUM $4.99B
1-Year Est. Return 23.08%
This Fund
S&P 500
This Quarter Est. Return
+11.63%
1 Year Est. Return
+23.08%
3 Year Est. Return
+101.05%
5 Year Est. Return
+118.22%
10 Year Est. Return
+474.28%
AUM
$3.21B
AUM Growth
+$299M
Cap. Flow
+$26.5M
Cap. Flow %
0.83%
Top 10 Hldgs %
24.3%
Holding
517
New
34
Increased
177
Reduced
237
Closed
22

Top Buys

Rank Stock Value
1
GPC icon
Genuine Parts
GPC
+$10.4M
2
KNSL icon
Kinsale Capital Group
KNSL
+$7.02M
3
PATH icon
UiPath
PATH
+$6.53M
4
QS icon
QuantumScape Corp
QS
+$4.78M
5
ORCL icon
Oracle
ORCL
+$4.11M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Financials 15.92%
3 Industrials 11.96%
4 Healthcare 9.47%
5 Consumer Discretionary 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPE icon
376
Expedia Group
EXPE
$39.1B
$420K 0.01%
3,050
-75
-2% -$10.7K
ET icon
377
Energy Transfer Partners
ET
$72.1B
$420K 0.01%
26,707
-10
-0% -$146
SMH icon
378
VanEck Semiconductor ETF
SMH
$72B
$417K 0.01%
1,855
+55
+3% +$11.1K
NTRS icon
379
Northern Trust
NTRS
$35B
$415K 0.01%
4,668
-500
-10% -$41K
MCO icon
380
Moody's
MCO
$82.8B
$410K 0.01%
1,043
-1
-0.1% -$386
STLD icon
381
Steel Dynamics
STLD
$37.7B
$408K 0.01%
2,753
DD icon
382
DuPont de Nemours
DD
$19.5B
$408K 0.01%
4,234
-3,585
-46% -$319K
FISV
383
Fiserv Inc
FISV
$27.4B
$407K 0.01%
2,544
-67
-3% -$9.76K
IOVA icon
384
Iovance Biotherapeutics
IOVA
$3.05B
$406K 0.01%
27,400
SCHO icon
385
Schwab Short-Term US Treasury ETF
SCHO
$12.9B
$404K 0.01%
16,778
-16,242
-49% -$392K
MTB icon
386
M&T Bank
MTB
$36.6B
$397K 0.01%
2,730
-175
-6% -$24.2K
VOOG icon
387
Vanguard S&P 500 Growth ETF
VOOG
$27.2B
$396K 0.01%
7,800
FNDX icon
388
Schwab Fundamental US Large Company Index ETF
FNDX
$27.4B
$390K 0.01%
17,382
+3,936
+29% +$83.7K
WPM icon
389
Wheaton Precious Metals
WPM
$61.3B
$384K 0.01%
8,142
ADM icon
390
Archer Daniels Midland
ADM
$38.4B
$383K 0.01%
6,103
+403
+7% +$23.7K
AVY icon
391
Avery Dennison
AVY
$13.7B
$383K 0.01%
1,715
KEY icon
392
KeyCorp
KEY
$24.5B
$381K 0.01%
24,098
TKR icon
393
Timken Company
TKR
$9.03B
$378K 0.01%
4,320
AVXL icon
394
Anavex Life Sciences
AVXL
$316M
$373K 0.01%
73,333
-327
-0.4% -$1.84K
FBIN icon
395
Fortune Brands Innovations
FBIN
$5.83B
$372K 0.01%
4,395
-385
-8% -$30.6K
FAST icon
396
Fastenal
FAST
$59.9B
$371K 0.01%
9,628
-1,186
-11% -$41.9K
AIG icon
397
American International
AIG
$39.8B
$366K 0.01%
4,680
-1,005
-18% -$71.7K
WAB icon
398
Wabtec
WAB
$49.9B
$365K 0.01%
2,505
-8
-0.3% -$1.08K
UL icon
399
Unilever
UL
$133B
$365K 0.01%
6,460
-2,891
-31% -$160K
IJK icon
400
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.2B
$365K 0.01%
3,996
-349
-8% -$29.1K

Similar funds

Carnegie Investment Counsel's Q1 2024 Portfolio in Review

As of Q1 2024, Carnegie Investment Counsel held 517 positions worth $3.21B, up 10% from $2.91B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Carnegie Investment Counsel's Q1 2024 filing shows 34 new, 177 increased, 237 reduced and 22 closed positions. Its largest new stake was UiPath: 279,145 shares worth $6.33M. The largest sale was Upstart Holdings, an estimated $7.01M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.

  • Carnegie Investment Counsel's largest Q1 2024 buy was UiPath: 279,145 shares worth $6.33M.
  • Carnegie Investment Counsel added most to Genuine Parts in Q1 2024, an estimated $10.4M increase.
  • Carnegie Investment Counsel's biggest Q1 2024 reduction was UnitedHealth, cutting an estimated $5.82M.
  • Carnegie Investment Counsel fully exited Upstart Holdings in Q1 2024, selling an estimated $7.01M.
  • Carnegie Investment Counsel's ten largest holdings make up 24% of its $3.21B portfolio in Q1 2024.
  • Carnegie Investment Counsel opened 34 new positions and closed 22 in Q1 2024.
  • Carnegie Investment Counsel's portfolio value rose 10% quarter-over-quarter to $3.21B.

Based on Carnegie Investment Counsel's 13F filing for Q1 2024, filed 6 May 2024.